Abstract
Objectives
It is to prospectively analyze nailfold capillaroscopy (NC) findings in new-onset dermatomyositis (DM) and to correlate NC findings with serum angiogenic cytokines and DM clinical and laboratory features.
Materials and methods
Twenty-three patients with DM who experienced < 12 months of symptoms were included in the study. To assess serum cytokine levels, 23 age-, sex-, and ethnicity-matched healthy volunteers were used. NC characteristics and DM activity parameters were analyzed.
Results
Significantly higher serum angiogenin (ANG) and vascular endothelial growth factor-1 (VEGF1) levels were observed in DM patients than in controls. Capillary density and avascular areas correlated positively and negatively, respectively, with serum levels of ANG. Moreover, the capillary density correlated inversely with the number of enlarged and giant capillaries and avascular areas. The number of enlarged capillaries correlated positively with patient and physician visual analogue scales (VAS), the presence of a facial rash, giant capillaries, and microhemorrhages. Giant capillaries had a positive correlation with physician and cutaneous VAS, enlarged capillaries, avascular areas, microhemorrhages and bushy capillaries, and a negative correlation with capillary density. Microhemorrhages correlated positively with the “V-neck” sign and physician VAS. VEGF1 showed no relationship with the NC parameters with DM-related clinical and laboratory features. Additionally, 15 out of 23 patients were assessed prospectively after 3.21 years. All patients had a major clinical response with significant improvement in all NC parameters, except for enlarged and bushy capillaries.
Conclusions
The NC may be a useful tool to assess disease activity in recent-onset DM, and it can also reinforce the role of ANG in the angiogenesis of this myopathy.
References
Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344–347
Dalakas MC (2011) Review: an update on inflammatory and autoimmune myopathies. Neuropathol Appl Neurobiol 37:226–242
Dalakas MC (2015) Inflammatory muscle diseases. N Engl J Med 373:1734–1747
Mainetti C, Terziroli Beretta-Piccoli B, Selmi C (2017) Cutaneous manifestations of dermatomyositis: a comprehensive review. Clin Rev Allergy Immunol 53:337–356
De Visser M, Emslie-Smith AM, Engel AG (1989) Early ultrastructural alterations in adult dermatomyositis. Capillary abnormalities precede other structural changes in muscle. J Neurol Sci 94:181–192
Emslie-Smith AM, Engel AG (1990) Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol 27:343–356
Lundberg IE, Grundtman C (2008) Developments in the scientific and clinical understanding of inflammatory myopathies. Arthritis Res Ther 10:220
Grundtman C, Tham E, Ulfgren AK, Lundberg IE (2008) Vascular endothelial growth factor is highly expressed in muscle tissue of patients with polymyositis and patients with dermatomyositis. Arthritis Rheum 58:3224–3238
Nagaraju K, Lundberg IE (2011) Polymyositis and dermatomyositis: pathophysiology. Rheum Dis Clin N Am 37:159–171
Kuwahara A, Jinnin M, Makino T, Kajihara I, Makino K, Honda N, Nakayama W, Inoue K, Fukushima S, Ihn H (2012) Angiogenin expression in the sera and skin of patients with rheumatic diseases. Biosci Trends 6:229–233
Ganczarczyk ML, Lee P, Armstrong SK (1988) Nailfold capillary microscopy in polymyositis and dermatomyositis. Arthritis Rheum 31:116–119
Blockmans D, Beyens G, Verhaeghe R (1996) Predictive value of nailfold capillaroscopy in the diagnosis of connective tissue diseases. Clin Rheumatol 15:148–153
Ohtsuka T (1998) The relation between nailfold bleeding and capillary microscopic abnormality in patients with connective tissue diseases. Int J Dermatol 37:23–26
Bergman R, Sharony L, Schapira D, Nahir MA, Balbir-Gurman A (2003) The handheld dermatoscope as a nail-fold capillaroscopic instrument. Arch Dermatol 139:1027–2030
Nagy Z, Czirják L (2004) Nailfold digital capillaroscopy in 447 patients with connective tissue disease and Raynaud’s disease. J Eur Acad Dermatol Venereol 18:62–68
Szabo N, Csiki Z, Szanto A, Danko K, SzodoraY P, Zeher M (2008) Functional and morphological evaluation of hand microcirculation with nailfold capillaroscopy and laser Doppler imaging in Raynaud’s and Sjögren’s syndrome and poly/dermatomyositis. Scand J Rheumatol 37:23–29
Mercer LK, Moore TL, Chinoy H, MurraY AK, Vail A, Cooper RG, Herrick AL (2010) Quantitative nailfold video capillaroscopy in patients with idiopathic inflammatory myopathy. Rheumatology 49:1699–1705
Selva-O’Callaghan A, Fonollosa-Pla V, Trallero-Araguas E, Martinez-Gomez X, Simeon-Aznar CP, Labrador-Horrilo M, Vilardell-Tarrés M (2010) Nailfold capillary microscopy in adults with inflammatory myopathy. Semin Arthritis Rheum 39:398–404
Mugii N, Hasegawa M, Matsushita T, Hamaguchi Y, Horie S, Yahata T, Inoue K, Someya F, Fujimoto M, Takehara K (2011) Association between nail-fold capillary findings and disease activity in dermatomyositis. Rheumatology (Oxford) 50:1091–1098
Pavlov-Dolijanovic S, Damjanov N, Stojanovic R, Vujasinovic Stupar N, Stanisavljevic D (2012) Scleroderma pattern of nailfold capillary changes as predictive value for the development of a connective tissue disease: a follow-up study of 3,029 patients with primary Raynaud’s phenomenon. Rheumatol Int 32:3039–3045
De Angelis R, Cutolo M, Gutierrez M, Bertolazzi C, Salaffi F, Grassi W (2012) Different microvascular involvement in dermatomyositis and systemic sclerosis. A preliminary study by a tight videocapillaroscopic assessment. Clin Exp Rheumatol 30:S67–S70
Manfredi A, Sebastiani M, Cassone G, Pipitone N, Giuggioli D, Colaci M, Salvarani C, Ferri C (2015) Nailfold capillaroscopic changes in dermatomyositis and polymyositis. Clin Rheumatol 34:279–284
Shenavandeh S, Zarei Nezhad M (2015) Association of nailfold capillary changes with disease activity, clinical and laboratory findings in patients with dermatomyositis. Med J Islam Repub Iran 29:233
Bertolazzi C, Cutolo M, Smith V, Gutierrez M (2017) State of the art on nailfold capillaroscopy in dermatomyositis and polymyositis. Semin Arthritis Rheum 47:432–444
Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, De Visser M et al (2017) International Myositis Classification Criteria Project Consortium, the Euromyositis Register, and the Juvenile Dermatomyositis Cohort Biomarker Study and Repository (UK and Ireland) 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups. Arthritis Rheum 69:2271–2282
Rider LG, Koziol D, Giannini EH, Jain MS, Smith MR, Whitney-Mahoney K, Feldman BM, Wright SJ, Lindsley CB, Pachman LM, Villalba ML, Lovell DJ, Bowyer SL, Plotz PH, Miller FH, Hicks JE (2010) Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies. Arthritis Care Res 62:465–472
Rider LG, Feldman BM, Perez MD, Rennebohm RM, Lindsley CB, Zemel LS, Wallace CA, Ballinger SH, Bowyer SL, Reed AM, Passo MH, Katona IM, Miller FW, Lachenbruch PA (1997) Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group Arthritis Rheum 40:1976–1983
Alexanderson H, Lundberg IE, Stenstrom CH (2002) Development of the myositis activities profile—validity and reliability of a self-administered questionnaire to assess activity limitations in patients with polymyositis/dermatomyositis. J Rheumatol 29:2386–2392
Isenberg DA, Allen E, Farewell V, Ehrenstein MR, Hanna MG, Lundberg IE et al International Myositis and Clinical Studies Group (IMACS) (2004) international consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford) 43:49–54
Aggarwal R, Rider LG, Ruperto N, Bayat N, Erman B, Feldman BM et al International Myositis Assessment and Clinical Studies Group and the Paediatric Rheumatology International Trials Organisation (2017) 2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: an International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organization Collaborative Initiative. Ann Rheum Dis 76:792–801
Cruellas MG, Viana V, Dos S, Levy-Neto M, Souza FH, Shinjo SK (2013) Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis. Clinics 68:909–914
Silva MG, Borba EF, Mello SB, Shinjo SK (2016) Serum adipocytokine profile and metabolic syndrome in young adult female dermatomyositis. Clinics 71:709–714
Maricq HR (1981) Wide field capillary microscopy. Arthritis Rheum 24:1159–1165
Ferrara N (1999) Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77:527–543
Gao X, Xu Z (2008) Mechanisms of action of angiogenin. Acta Biochim Biophys Sin Shanghai 40:619–624
Kikuchi K, Kubo M, Kadono T, Yazawa N, Ihn H, Tamaki K (1998) Serum concentrations of vascular endothelial growth factor in collagen diseases. Br J Dermatol 139:1049–1051
Cutolo M, Sulli A, Smith V (2013) How to perform and interpret capillaroscopy. Best Pract Res Clin Rheumatol 27:237–248
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The study was approved by the local ethics committee.
Disclosures
None.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Miossi, R., de Souza, F.H.C. & Shinjo, S.K. Nailfold capillary changes in adult new-onset dermatomyositis: a prospective cross-sectional study. Clin Rheumatol 38, 2319–2326 (2019). https://doi.org/10.1007/s10067-019-04537-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-019-04537-x